JAMA Oncology’s Post

Most viewed in the last 7 days from JAMA Network Open: In patients with early-onset colorectal cancer (EOCRC), what are the most common presenting signs and symptoms, what is their association with EOCRC risk, and what is the time from presentation to diagnosis? https://ja.ma/4bYsjY5

📣 Key prostate cancer and PSA statistics reinforcing the importance of testing. An annual PSA test can identify potential issues with your prostate. Early diagnosis can improve your treatment options and success. Don't wait for symptoms. Get tested. Book here - mypsatests.org.uk 💙

Most viewed in the last 7 days from JAMA Network Open: In patients with early-onset colorectal cancer (EOCRC), what are the most common presenting signs and symptoms, what is their association with EOCRC risk, and what is the time from presentation to diagnosis? https://ja.ma/4aC69db

New 3i Investigator Article Alert!! Longitudinal associations of plasma kynurenines and ratios with fatigue and quality of life in colorectal cancer survivors up to 12 months post-treatment https://lnkd.in/gejrHeAH

·        ESD is effective for treating Early Gastric Cancer (EGC) and western experience for absolute indication (AI) ECG continues to grow.   ·       Data in comorbid patients with more advanced EGC is limited (termed relative indication (RI).  ·       We analyzed our experience in 157 EGC in 149 patients (mean size 30mm).  ·      Over F/U of 52 months in a comorbid group (Charlson CI 4.2), between AI and RI EGC, 5-year Overall Survival (88.9 VS 77.9%) and DFS (83.2 vs 75.1%) were not significantly different.  ·        No serious AE occurred after ESD. ·        RI EGC had more advanced histology with higher rates of poorly. differentiated lesions (37.5% vs1.8%, P < 0.001), lymphovascular invasion (LVI) (39.6% vs 3.7%, P < 0.001), SMIC (72.9% vs 15.6%, P <0.001), and ulceration (54.2% vs 13.8%, P < 0.001). ·        Despite these adverse features only 1 patient died of gastric cancer. ·        Hence ESD for RI EGC in the comorbid is safe and highly effective treatment, achieving DFS in the majority in long term FU. This article is now in GIE’s Articles in Press, has been posted on LinkedIn account at https://lnkd.in/gXewwSZs. Please read and enjoy!

Our latest study, exploring the experiences of colorectal cancer (CRC) patients with their family practitioners in Canada was published in Current Oncology. This study explores CRC patients experiences throughout their diagnosis journey. Learn more about the study by clicking the link below.

FORTE is a colorectal cancer prevention study looking to determine how often participants who have had 1-2 benign polyps removed from their colon should have repeat monitoring colonoscopies. Learn more: https://lnkd.in/gUsZxnE8

Feeling fatigued from battling breast cancer? Discover how exercise can boost your energy levels and overall well-being! 🌟 #BreastCancerAwareness #ExerciseForHealth #StayStrong Check out our blog post https://wix.to/tU1PMSU #newblogpost

Take Charge Of Your Health With Monthly Self-Exams. Perform a self exam once a month and watch for any unusual changes. Self exams and regular mammograms can help detect breast cancer early leading to better treatment outcomes. Schedule your FREE Consultation and Discounted Breast Scan (50% off) throughout this month of October. #BreastCancerAwareness #SelfExam #EarlyDetectionSavesLives #PrioritizeHealth

For patients with a new diagnosis of kidney cancer, it's important to learn kidney anatomy. In this video, we discuss the function, and location of the kidneys and their surrounding organs to understand treatment options and their risks and side effects. https://lnkd.in/eARJ93tC